Dora Hammerl
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
-
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Immunology 11
- Immunotherapy and Immune Responses 8
- Immune Cell Function and Interaction 2
- T-cell and B-cell Immunology 2
- Immune cells in cancer 2
- Oncology 12
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 6
- Co-authors
- Reno Debets (12 shared papers)John Martens (7 shared papers)Marcel Smid (6 shared papers)Stefan Sleijfer (1 shared paper)A. Mieke Timmermans (1 shared paper)Marleen Kok (2 shared papers)Hayri Emrah Balcioglu (3 shared papers)Rebecca Wijers (4 shared papers)
- Journals
- Trends in Immunology (2 papers)The Journal of Immunology (1 paper)Scientific Reports (1 paper)Cancers (1 paper)Modern Pathology (1 paper)
- Partner nations
- NetherlandsAustraliaBelgium
In The Last Decade
Dora Hammerl
13 papers receiving 474 citations
Peers
Comparison fields: 5 of 53
- Oncology 256
- Immunology 175
- Cancer Research 100
- Molecular Biology 156
- Pulmonary and Respiratory Medicine 34
Countries citing papers authored by Dora Hammerl
This map shows the geographic impact of Dora Hammerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Hammerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Hammerl more than expected).
Fields of papers citing papers by Dora Hammerl
This network shows the impact of papers produced by Dora Hammerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Hammerl. The network helps show where Dora Hammerl may publish in the future.
Co-authors
The 25 scholars most cited alongside Dora Hammerl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 168 | |
| 2 | 2017 | 131 | |
| 3 | 2019 | 39 | |
| 4 | 2018 | 36 | |
| 5 | 2018 | 33 | |
| 6 | 2018 | 31 | |
| 7 | 2021 | 14 | |
| 8 | 2022 | 9 | |
| 9 | 2024 | 8 | |
| 10 | 2025 | 7 | |
| 11 | 2024 | 3 | |
| 12 | 2022 | 1 | |
| 13 | 2022 | 1 | |
| 14 | 2021 | 0 |
About Dora Hammerl
Dora Hammerl is a scholar working on Immunology, Oncology, Cancer Research, Molecular Biology and Hematology, having authored 14 papers that have together received 481 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (8 papers), CAR-T cell therapy research (6 papers), CRISPR and Genetic Engineering (2 papers), Cancer Genomics and Diagnostics (2 papers), Immune Cell Function and Interaction (2 papers), T-cell and B-cell Immunology (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Oncology (256 citations), Immunology (175 citations), Cancer Research (100 citations), Molecular Biology (156 citations) and Pulmonary and Respiratory Medicine (34 citations). Dora Hammerl has collaborated with scholars based in Netherlands, Australia and Belgium. Frequent co-authors include Reno Debets, John Martens, Marcel Smid, Stefan Sleijfer, A. Mieke Timmermans, Marleen Kok, Hayri Emrah Balcioglu, Rebecca Wijers, Anita Trapman-Jansen and Mieke A. M. Timmermans. Their work appears in journals such as Trends in Immunology, The Journal of Immunology, Scientific Reports, Cancers and Modern Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.